Literature DB >> 6407542

Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982).

E A McCulloch.   

Abstract

This paper deals with three themes: (1) the nature of differentiation in normal and leukemic processes, (2) stochastic and deterministic control mechanisms that affect differentiation, and (3) the nature of the events that separate self-renewing stem cells from their committed descendants. These all impinge on both myelopoietic and lymphopoietic leukemias. The view is advanced that differentiation continues in these diseases, but new programs are assembled abnormally but with normal components.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407542

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  62 in total

Review 1.  Acute myelogenous leukaemia in children.

Authors:  S O Lie
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 2.  Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.

Authors:  Roland B Walter; Frederick R Appelbaum; Elihu H Estey; Irwin D Bernstein
Journal:  Blood       Date:  2012-01-27       Impact factor: 22.113

3.  Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin.

Authors:  J T Elder; W C Forrester; C Thompson; D Mager; P Henthorn; M Peretz; T Papayannopoulou; M Groudine
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.

Authors:  E Backé; R Schwarting; J Gerdes; M Ernst; H Stein
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

Review 5.  Biology and relevance of human acute myeloid leukemia stem cells.

Authors:  Daniel Thomas; Ravindra Majeti
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

6.  Establishment of the DU.528 human lymphohemopoietic stem cell line.

Authors:  J Kurtzberg; S H Bigner; M S Hershfield
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

Review 7.  Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.

Authors:  Valeriy Sedov; Robert K Stuart
Journal:  Ther Adv Hematol       Date:  2017-04-21

8.  Congenital protein C deficiency and thrombotic disease in nine French families.

Authors:  M H Horellou; J Conard; R M Bertina; M Samama
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

9.  LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.

Authors:  S Oez; U Trautmann; M Smetak; J Birkmann; S al salemeh; E Gebhart; W M Gallmeier
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

10.  Scanning electron microscopic observation of CFU-mix of normal adults and leukemic patients including two cases of myeloid-lymphoid bipotent leukemia.

Authors:  Y Chen; B M Wang; C Y Li; D J Yu
Journal:  J Tongji Med Univ       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.